Erythropoietin treatments may increase hip fracture risk in patients with kidney failure

Oregon extends COVID workplace mask rule indefinitely
5 May 2021
Can Twitter help improve dental education?
5 May 2021

Erythropoietin treatments may increase hip fracture risk in patients with kidney failure

Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.

Comments are closed.